Home › Funds › Aristotle Atlantic Partners, LLC › DXCM

Aristotle Atlantic Partners, LLC position in DXCM

DEXCOM INC · Health Care

Aristotle Atlantic Partners, LLC reported holding 349,417 shares of DXCM (DEXCOM INC) in its Q2 2026 13F filing — a position valued at US$23.5M, representing 0.98% of its reported portfolio and ranking #36 among its reported holdings. Aristotle Atlantic Partners, LLC has disclosed DXCM holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)349.42K sh
Reported value held$23.53M
Portfolio Weight0.98%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Aristotle Atlantic Partners, LLC's DXCM position evolved

Aristotle Atlantic Partners, LLC first disclosed a stake in DXCM in Q3 2023 at 200,831 shares (US$18.7M). The position peaked in Q1 2024 at 200,462 shares, worth US$27.8M. Across 9 filings, Aristotle Atlantic Partners, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 349,417 shares valued at US$23.5M — an increase of 97,932 shares quarter over quarter.. Notable position changes include a 39% increase in Q2 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 200.83K $18.74M New
Q4 2023 203.15K $25.21M Add
Q1 2024 200.46K $27.80M Reduce
Q2 2024 199.25K $22.59M Reduce
Q3 2024 199.44K $13.37M Hold
Q3 2025 193.28K $13.01M New
Q4 2025 235.61K $15.64M Add
Q1 2026 251.49K $15.79M Add
Q2 2026 349.42K $23.53M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DXCM and 13F data

DXCM (DEXCOM INC) is a Health Care company. 27 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$996.9M), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DXCM

All DXCM fund holders →

FAQ

How long has Aristotle Atlantic Partners, LLC held DXCM?

Aristotle Atlantic Partners, LLC has disclosed DXCM holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is Aristotle Atlantic Partners, LLC's current position in DXCM?

As of Q2 2026, Aristotle Atlantic Partners, LLC holds 349.42K shares of DXCM (DEXCOM INC), valued at $23.53M, representing 0.98% of its reported portfolio and ranking #36.

Has Aristotle Atlantic Partners, LLC been buying or selling DXCM?

In the latest 13F filing (Q2 2026), Aristotle Atlantic Partners, LLC increased its position in DXCM. The position peaked in Q1 2024 at 200.46K shares.

Which other funds hold DXCM?

Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.